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Most individuals with congenital achromatopsia (ACHM) carry mutations that affect the
retinal phototransduction pathway of cone photoreceptors, fundamental to both high
acuity vision and colour perception. As the central fovea is occupied solely by cones,
achromats have an absence of retinal input to the visual cortex and a small central area
of blindness. Additionally, those with complete ACHM have no colour perception, and
colour processing regions of the ventral cortex also lack typical chromatic signals from
the cones. This study examined the cortical morphology (grey matter volume, cortical
thickness, and cortical surface area) of multiple visual cortical regions in ACHM (n = 15)
compared to normally sighted controls (n = 42) to determine the cortical changes that
are associated with the retinal characteristics of ACHM. Surface-based morphometry
was applied to T1-weighted MRI in atlas-defined early, ventral and dorsal visual regions
of interest. Reduced grey matter volume in V1, V2, V3, and V4 was found in ACHM
compared to controls, driven by a reduction in cortical surface area as there was no
significant reduction in cortical thickness. Cortical surface area (but not thickness) was
reduced in a wide range of areas (V1, V2, V3, TO1, V4, and LO1). Reduction in early
visual areas with large foveal representations (V1, V2, and V3) suggests that the lack
of foveal input to the visual cortex was a major driving factor in morphological changes
in ACHM. However, the significant reduction in ventral area V4 coupled with the lack
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of difference in dorsal areas V3a and V3b suggest that deprivation of chromatic signals
to visual cortex in ACHM may also contribute to changes in cortical morphology. This
research shows that the congenital lack of cone input to the visual cortex can lead to
widespread structural changes across multiple visual areas.
Keywords: achromatopsia, congenital visual impairment, anatomical brain regions, visual areas, structural
plasticity, parallel visual pathways, ventral and dorsal pathways
INTRODUCTION
Congenital achromatopsia (ACHM; also known as rod
monochromacy) is a largely stationary, genetically heterogeneous
and predominantly autosomal recessive retinal disorder with
a prevalence of approximately ∼1 in 30,000 people (Francois,
1961; Kohl et al., 2004; Aboshiha et al., 2016). Most cases are
caused by mutations in one of the several genes expressed in the
retinal phototransduction pathway of the cone photoreceptor. As
a result, ACHM is characterised by a lack of function in all three
cone photoreceptors from birth. The functional integrity of cone
photoreceptors is fundamental for the mediation of photopic
(bright light) vision, high visual acuity and colour perception. In
the normally-sighted, the central fovea of the retina is composed
exclusively of cone photoreceptors providing high visual acuity.
With only functioning rods, individuals with complete ACHM
have a central scotoma where rods are absent and a complete
loss of colour vision from birth, along with reduced visual acuity
(Haegerstrom-Portnoy et al., 1996a,b; Remmer et al., 2015;
Hirji et al., 2018). In normally-sighted individuals, the foveal
region of the visual field dominated by cones is overrepresented
in the visual cortex (cortical magnification). Crucially, this
means that in ACHM a disproportionately large area of the
visual cortex receives atypical input due to the defective cone
photoreceptors. Thus, it is possible that the lack of visual input
to foveal representations within visual regions throughout the
cortex may influence the structural characteristics of the visual
cortex within this patient population.
The brain contains multiple representations of the visual field,
becoming functionally specialised along the visual processing
hierarchy. Beyond early occipital areas V1, V2, and V3, higher
areas in the ventral stream are important for colour, pattern and
shape/form processing (Zeki et al., 1991; McKeefry and Zeki,
1997; Wade et al., 2002; Goddard et al., 2011; Winawer and
Witthoft, 2015), while dorsal areas are involved in the analysis
of spatial characteristics such as object motion, position, depth
and visually guided grasping (Ungerleider and Mishkin, 1982;
Goodale and Milner, 1992). In particular, human ventral area V4
responds most strongly to chromatic stimuli (Zeki et al., 1991;
Wade et al., 2002; Goddard et al., 2011), and responses in ventral
occipital cortex (VO) have been correlated with the perceptual
experience of colour (Jiang et al., 2007). Furthermore, damage
to ventral areas such as V4 leads to a loss of colour perception
(cerebral achromatopsia) (Zeki, 1990). Given the importance of
cones for colour perception and high acuity vision needed for
processing shape/form, it is possible that lack of cone input in
ACHM might affect ventral visual areas more significantly than
dorsal areas. Indeed, a behavioural study by Burton et al. (2016)
supports this hypothesis, reporting that individuals with ACHM
are more impaired in global form perception relative to global
motion and biological motion perception.
To date, at least five genes, GNAT2, PDE6C, PDE6H, CNGA3,
and CNGB3, have been identified as responsible for over 90% of
congenital ACHM cases (Wissinger et al., 2001; Johnson et al.,
2004; Varsányi et al., 2005; Thiadens et al., 2009; Liang et al.,
2015; Zelinger et al., 2015; Sun et al., 2020). Of these, the vast
majority are caused by mutations in either CNGA3 or CNGB3
genes (Kohl et al., 2004; Liang et al., 2015; Zelinger et al.,
2015; Sun et al., 2020). Current clinical trials are testing gene-
therapeutic interventions to treat congenital ACHM by restoring
cone function in the eye (Fischer et al., 2020; Reichel et al., 2021;
NCT03758404, NCT03001310, NCT03278873, NCT02935517,
NCT02599922, and NCT02610582).
The consequences of potential cortical changes in ACHM on
efforts to restore vision are currently unknown. However, we
can draw on changes to the posterior visual pathway that have
been documented in other visual deficits to provide some context
(Prins et al., 2016). Previous research has reported significant
structural changes in visual processing pathways in the brain
both in individuals with congenital blindness (Ptito et al., 2008;
Jiang et al., 2009; Park et al., 2009; Aguirre et al., 2016; Bridge
and Watkins, 2019) and acquired defects (Boucard et al., 2009;
Hernowo et al., 2014; Brown et al., 2016; Prins et al., 2016; Hanson
et al., 2019). Functional changes have been identified in another
ophthalmological disorder, i.e., amblyopia, in higher visual areas
including V4 and MT+ (Wong, 2012). Structural changes have
also been reported in totally blind individuals specifically in
connectivity to the ventral visual areas (Reislev et al., 2016a,b).
In models of glaucoma, it is evident that the posterior visual
pathway undergoes degeneration, which would likely prevent full
restoration of vision (Yucel and Gupta, 2015). If cortical atrophy
is detected in ACHM, it is possible that degeneration has occurred
and could limit restoration of vision.
Efforts to restore vision in different disorders have been
cautiously optimistic, but have produced mixed results. In
late-onset disorders such as age-related cataract, visual acuity
immediately improves following corrective surgery, and this is
associated with an increase in grey matter volume of visual
brain areas (Lou et al., 2013; Lin et al., 2018). Similarly,
in late-blind participants with retinitis pigmentosa, motion
detection and BOLD responses to visual stimuli were enhanced
following implantation of a retinal prosthesis even after years
of deprivation (Castaldi et al., 2016). However, visual recovery
evident in these studies may have been strictly dependent on
the presence of early visual experience during childhood (Hadad
et al., 2015). In early-onset disorders, such visual experience is
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absent. Even when the optical image has been fully restored
following surgery, vision is not always restored to normal. In
cases of early blindness due to corneal opacity, after corneal
replacement participants still perform poorly on higher level
visual tasks requiring shape, object and face processing (Fine
et al., 2003) or colour discrimination (Ackroyd et al., 1974).
Following surgery to correct congenital cataract, the degree of
vision restoration is inversely related to the extent of changes in
visual cortex (Guerreiro et al., 2015, 2016). Overall, these studies
suggest that restoring vision to normal must involve normal
cortical function and that anatomical biomarkers could provide
a valuable indicator of the extent to which function may return to
normal, particularly in the case of a congenital deficit.
Using gene therapeutic interventions, such as those well
established in Leber’s Congenital Amaurosis, visual and
behavioural outcomes have also been variable (for review see:
Chiu et al., 2021). However, evidence that cortical plasticity
is still possible later in life was provided by an fMRI study
reporting increased responses in visual cortex following gene
therapy when participants with Leber’s Congenital Amaurosis
were treated in adulthood (Mowad et al., 2020). In ACHM,
early studies also report promising but variable results following
gene therapy (Farahbakhsh et al., 2020; Fischer et al., 2020;
Reichel et al., 2021). In a study of two adult ACHM participants,
minor improvements in visual acuity and a reduction in levels
of photoaversion were found following treatment (McKyton
et al., 2021). Furthermore, population receptive field sizes were
reduced in early visual areas following treatment, suggesting
that some restoration of cortical function is possible. However,
although participants were now able to detect differences in
the red end of the spectrum, there was no improvement in
colour discrimination nor were fMRI responses detectable in
colour-specific brain areas. The absence of improved colour
discrimination could be due to insufficient restoration of retinal
function or due to limitations in visual cortex. Nevertheless, a
lack of colour responses in extrastriate brain areas along with
an inability to discriminate colours suggest that long-term
deficits may persist.
The aim of the current study was to evaluate how the
deprivation of foveal and chromatic vision in participants
with ACHM affect the development and structural integrity of
multiple visual regions in striate and extrastriate cortex. Given
the absence of functioning cones in ACHM, we hypothesised
that ventral visual areas would be more affected than dorsal
areas. We found that early visual areas V1 to V3 exhibit atrophic
changes in ACHM. Similar changes were also present in ventral
region V4, but not in dorsal areas V3a and V3b at an equivalent
level in the visual hierarchy. We provide evidence therefore
that the structural development of visual brain areas driven
predominantly by cone input is particularly affected in ACHM.
MATERIALS AND METHODS
Participants
High resolution structural scans were collected at three sites
from 42 control participants with normal or corrected to
normal vision (mean age ± SD: 30.29 ± 9.72 years; 19 males)
and 15 participants with both genetically confirmed ACHM
(biallelic CNGA3 (n = 10) or CNGB3 (n = 5) mutations; see
Table 1) and electroretinographically confirmed absence of cone
function (mean age ± SD: 36.73 ± 10.95 years; 9 males). An
independent samples t-test between groups found no significant
age difference between groups [t(55) = −2.02. p = 0.056].
However, given the difference in mean age was close to the
p < 0.05 cut-off, a subsequent analysis assessed age as a possible
confound, along with scanner site, gender, and global metrics (see
section “Results”).
Experimental protocols received approval from the site-
specific ethics committees and were in accordance with the
Declaration of Helsinki.
MRI Protocol
University of York (10 Controls, 4 Achromatopsia)
A single, high resolution, anatomical, T1-weighted scan (TR,
2500 ms; TE, 2.26ms; TI, 900 ms; voxel size, 1 × 1 × 1 mm3; flip
angle, 7◦; matrix size, 256 × 256 × 176, total acquisition time,
306 s) was acquired on each participant using a 64-channel head
coil on a SIEMENSMAGNETOMPrisma 3T scanner at the York
Neuroimaging Centre (YNiC).
Hadassah Medical Centre (24 Controls, 6
Achromatopsia)
A single, high resolution, anatomical, T1-weighted scan (TR,
2300 ms; TE, 1.5 ms; TI, 900 ms; voxel size, 1 × 1 × 1 mm3;
flip angle, 9◦; matrix size, 256 × 256 × 160, total acquisition
time, 278 s) was acquired on each participant using a 32-channel
head coil on a SIEMENS MAGNETOM Skyra 3T scanner at
the Edmond & Lily Safra Centre for Brain Sciences, Hebrew
University of Jerusalem.
University of Magdeburg (8 Controls, 5
Achromatopsia)
A single, high resolution, anatomical, T1-weighted scan (TR,
2500 ms; TE, 2.82 ms; TI, 1100 ms; voxel size, 1 × 1 × 1 mm3;
flip angle, 7◦; matrix size, 256 × 256 × 192, total acquisition
time, 560 s) was acquired on each participant using a 64-channel
head coil on a SIEMENSMAGNETOM Prisma 3T scanner at the
University Hospital, Magdeburg, Germany.
Data Pre-processing
Cortical reconstruction and volumetric segmentation of the T1-
weighted scans and surface-based morphology analysis were
performed using the Freesurfer analysis suite Version 6.0
(Dale et al., 1999; Fischl et al., 1999). This included the
removal of non-brain tissue (Ségonne et al., 2004), automated
Talairach transformation, intensity normalisation (Sled et al.,
1998), tessellation of the grey/white matter and pial boundaries
(grey/cerebrospinal fluid) with automated topology correction
and surface deformation (Dale et al., 1999; Fischl et al., 1999;
Ségonne et al., 2007). Subsequently, the cortical surface was
inflated and registered to a sphere (Fischl et al., 1999) and
the surface parcellated according to gyral and sulcal structures
(Ségonne et al., 2004; Desikan et al., 2006).
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TABLE 1 | Summary of patient demographics showing participant group (ACHM,
participants with congenital achromatopsia; C, control participants), gender (m,
male; f, female), age, scanner site (HMC, Hadassah Medical Centre; UM,
University of Magdeburg; UY, University of York), and genotype.
Participant Gender Age Site Genotype
ACHM m 34 HMC CNGA3
ACHM m 41 HMC CNGA3
ACHM m 35 HMC CNGA3
ACHM f 41 HMC CNGA3
ACHM f 42 HMC CNGA3
ACHM m 28 HMC CNGA3
ACHM m 18 UM CNGB3
ACHM f 55 UM CNGA3
ACHM f 29 UM CNGB3
ACHM m 45 UM CNGB3
ACHM m 22 UM CNGA3
ACHM f 40 UY CNGB3
ACHM m 28 UY CNGB3
ACHM m 34 UY CNGA3
ACHM f 51 UY CNGA3
C m 25 HMC –
C f 33 HMC –
C m 19 HMC –
C f 22 HMC –
C f 24 HMC –
C m 34 HMC –
C f 27 HMC –
C m 26 HMC –
C m 29 HMC –
C f 29 HMC –
C f 24 HMC –
C f 32 HMC –
C f 46 HMC –
C f 30 HMC –
C f 22 HMC –
C f 57 HMC –
C f 23 HMC –
C m 23 HMC –
C m 50 HMC –
C m 43 HMC –
C f 25 HMC –
C f 27 HMC –
C m 26 HMC –
C m 25 HMC –
C m 33 UM –
C f 58 UM –
C m 29 UM –
C m 27 UM –
C f 32 UM –
C f 53 UM –
C f 35 UM –
C m 27 UM –
C f 26 UY –
C f 26 UY –
C m 35 UY –
C m 29 UY –
(Continued)
TABLE 1 | (Continued)
Participant Gender Age Site Genotype
C f 23 UY –
C m 24 UY –
C f 30 UY –
C m 23 UY –
C f 19 UY –
C m 22 UY –
The final surface reconstruction was inspected for potential
cortical segmentation errors (for example areas where dura
mater was incorrectly included in the grey matter surface
during the initial automated segmentation) and, when necessary,
manually corrected using the FreeView Visualisation GUI.
Manual editing was split between two expert observers who
were blind to participant identity and group to avoid bias.
Minor edits to the pial surface were made in 50% of ACHM
and 50% of control participants. Edits were primarily of the
skull and dura mater located at parietal, motor and frontal
cortical regions with only a small minority of participants
requiring edits in the occipital cortex. All manually corrected
reconstructions were rerun (‘autoreconall2’) utilising the edited
brainmask.mgz files.
Data Analysis
A subsequent region-of-interest (ROI)-based analysis was
applied where we compared differences in three surface-based
measures between ACHM and their demographically matched
controls: mean cortical volume (mm3), cortical thickness (mm)
and surface area (mm2).
Cortical volume was computed as described in Winkler
et al. (2018). Briefly, three vertices defining a face in the
white surface and three matching vertices in the pial surface
form an oblique truncated triangular pyramid; the volumes
of these are subsequently computed and summed together
for the whole ROI. Cortical thickness was defined as the
shortest distance between each grey/white matter boundary
vertex and the pial surface (grey matter/cerebrospinal fluid
boundary) and vice versa. The final value depicted the
average of the two thickness values measured, and thickness
values were then averaged across each ROI (Fischl and
Dale, 2000). Surface area was measured by calculating the
summed surface area across each ROI of each triangle of the
surface mesh, the unit used to connect the cortical surface
between each vertex.
Regions-of-interest used for this analysis stream were derived
using the anatomically defined retinotopy atlas (Benson et al.,
2014) implemented in the python analysis toolbox ‘neuropythy’
(Benson and Winawer, 2018). The atlas then predicted several
Freesurfer-based maps (visual area, eccentricity, polar angle, and
pRF size), which were used to delineate twelve ROI labels for
each participant. The ROIs encompass the entire cortical field
representations of areas V1, V2, V3, V3a, V3b, TO1, TO2, V4,
VO1, VO2, LO1, and LO2 (Figure 1A).
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FIGURE 1 | Regions of interest and mean grey matter volume, cortical
thickness and surface area for ACHM and controls. (A) An inflated surface of
one control participant showing the cortical surface of the atlas-defined brain
areas used in analysis (Benson et al., 2014; Benson and Winawer, 2018;
https://osf.io/knb5g/). (B) A violin plot showing the distribution of mean grey
matter volume averaged across the two hemispheres of controls and ACHM
for each ROI. Horizontal lines within the violins indicate means for each group.
Red stars indicate significant differences between groups in post hoc
comparisons (p < 0.05). (C) A violin plot showing the distribution of mean
cortical thickness averaged across the two hemispheres of controls and
ACHM for each ROI. Details as in (B). (D) A violin plot showing the distribution
of mean cortical surface area averaged across the two hemispheres of
controls and ACHM for each ROI. Details as in (B). Red stars indicate
significant differences between groups in post hoc comparisons (p < 0.05).
RESULTS
First, the data were evaluated from each hemisphere separately.
A 2 × 2 × 12 mixed measures ANOVA was performed with
between-subjects factor participant group (2 levels – ACHM and
controls), and within-subjects factors of hemisphere (2 levels –
left and right) and ROI (12 levels). Huynh-Feldt correction
was applied to correct for sphericity of the data. There was no
significant interaction between participant group, hemisphere,
and ROI in any of the three metrics (Supplementary Table 1).
Since hemisphere will have no effect on any interaction found
between participant group and ROI, the data were combined
across hemispheres. Extracted values of surface area and volume
were averaged for each ROI and for each participant. For cortical
thickness, the values were weighted by the respective surface area
value and the mean cortical thickness. Values were derived by
summing the product of the thickness and surface areas on the
right and left hemispheres, respectively, and dividing this by the








Results of the data averaged across hemispheres are shown in
Figures 1B–D. To determine whether the effects of age, scanner
site, gender, and global brain metrics influenced any of the three
outcome measures, these variables were entered as potential
confounds using analysis of covariance (ANCOVA). Repeated
measures ANCOVAs were performed for each measurement type
(grey matter volume, cortical thickness, and cortical surface area)
including the two main variables of interest: participant group (2
levels) and ROI (12 levels). Huynh-Feldt correction was applied
to correct for sphericity of the data.
There was no significant main effect of age, gender, scanner
site or global brain metrics, and no interactions between any
of these variables and participant group. The only significant
interaction between the potential confounds and variables
of interest was in grey matter volume for ROI × scanner
site × gender [F(8.44, 181.56) = 2.64, p = 0.008]. This may
reflect the differing number of each gender at each scanner site.
All potential confounds are nevertheless accounted for in the
remaining results (see Table 2).
The main effect of participant group was significant for
grey matter volume [F(1,43) = 4.87, p = 0.033] and surface
area [F(1,43) = 7.52, p = 0.009] but was not significant for
cortical thickness [F(1,43) < 0.01, p = 0.962]. This indicates that
mean volume and surface area are reduced overall in all visual
areas tested here in ACHM compared to controls, as seen in
Figure 1. The main effect of ROI was significant for grey matter
volume [F(4.22, 181.56) = 3.63, p = 0.006] but not for cortical
thickness [F(11, 473) = 1.11, p = 0.352] or surface area [F(2.26,
97.28) = 0.064]. This is expected, as differences in visual area
size are well documented in the literature (Wandell et al., 2007).
Critically, however, the interaction between ROI and participant
group was also significant for volume [F(4.22, 181.56) = 4.85,
p = 0.001] and surface area [F(2.26, 97.28) = 6.62, p = 0.001],
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TABLE 2 | Results of analysis of covariance to assess effects of possible
confounds age, scanner site, gender and global metrics.
Source df1, df2 F p Effect size
Grey matter volume
Participant group (A) 1, 43 4.87 0.033 0.10
ROI (B) 4.22, 181.56 3.63 0.006 0.08
Scanner site (C) 2, 43 0.61 0.549 0.03
Age (D) 1, 43 1.10 0.299 0.03
Gender (E) 1, 43 0.30 0.587 0.01
Global volume (F) 1, 43 0.95 0.335 0.02
A × B 4.22, 181.56 4.85 0.001 0.10
A × C 2, 43 0.02 0.976 0.00
A × E 1, 43 0.00 0.963 0.00
A × B × C 8.44, 181.56 0.39 0.934 0.02
A × B × E 4.22, 181.56 0.86 0.492 0.02
A × C × E 2, 43 0.08 0.920 0.00
A × B × C × E 8.44, 181.56 0.30 0.968 0.01
B × C 8.44, 181.56 1.19 0.308 0.05
B × D 4.22, 181.56 2.14 0.074 0.05
B × E 4.22, 181.56 0.53 0.723 0.01
B × F 4.22, 181.56 0.48 0.764 0.01
B × C × E 8.44, 181.56 2.64 0.008 0.11
C × E 2, 43 0.77 0.471 0.03
Cortical thickness
Participant group (A) 1, 43 0.00 0.962 0.00
ROI (B) 11.00, 473.00 1.11 0.352 0.03
Scanner site (C) 2, 43 0.86 0.432 0.04
Age (D) 1, 43 0.03 0.861 0.00
Gender (E) 1, 43 0.20 0.658 0.01
Global thickness (F) 1, 43 0.51 0.478 0.01
A × B 11.00, 473.00 1.55 0.112 0.04
A × C 2, 43 0.66 0.522 0.03
A × E 1, 43 0.00 0.948 0.00
A × B × C 22.00, 473.00 0.85 0.666 0.04
A × B × E 11.00, 473.00 0.61 0.823 0.01
A × C × E 2, 43 2.94 0.064 0.12
A × B × C × E 22.00, 473.00 0.68 0.862 0.03
B × C 22.00, 473.00 0.79 0.746 0.04
B × D 11.00, 473.00 0.65 0.783 0.02
B × E 11.00, 473.00 0.54 0.875 0.01
B × F 11.00, 473.00 0.86 0.582 0.02
B × C × E 22.00, 473.00 0.50 0.975 0.02
C × E 2, 43 3.68 0.033 0.15
Cortical surface area
Participant group (A) 1, 43 7.52 0.009 0.15
ROI (B) 2.26, 97.28 2.72 0.064 0.06
Scanner site (C) 2, 43 0.34 0.712 0.02
Age (D) 1, 43 1.79 0.188 0.04
Gender (E) 1, 43 0.20 0.656 0.01
Global surface area (F) 1, 43 0.71 0.403 0.02
A × B 2.26, 97.28 6.62 0.001 0.13
A × C 2, 43 0.03 0.968 0.00
A × E 1, 43 0.10 0.749 0.00
A × B × C 4.53, 97.28 0.10 0.989 0.01
A × B × E 2.26, 97.28 0.81 0.459 0.02
(Continued)
TABLE 2 | (Continued)
Source df1, df2 F p Effect size
A × C × E 2, 43 0.62 0.542 0.03
A × B × C × E 4.53, 97.28 0.46 0.788 0.02
B × C 4.53, 97.28 0.71 0.601 0.03
B × D 2.26, 97.28 2.89 0.054 0.06
B × E 2.26, 97.28 0.05 0.967 0.00
B × F 2.26, 97.28 0.61 0.565 0.01
B × C × E 4.53, 97.28 2.35 0.052 0.10
C × E 2, 43 0.27 0.765 0.01
Effect size shown is partial eta-squared. Huynh-Feldt correction applied to correct
for violation of sphericity. Significance is illustrated by boldface.
but was not significant for cortical thickness [F(11,473) = 1.55,
p = 0.112]. Considering these interactions, we performed post hoc
pairwise comparisons to determine if there was a significant
difference between ACHM participants and controls in grey
matter volume and surface area for each of the 12 ROIs, adjusting
for multiple comparisons using Bonferroni correction (Table 3).
This analysis revealed four areas which showed a significant
difference between ACHM and controls for grey matter volume
(V1: p = 0.006, V2: p = 0.019, V3: p = 0.024, V4, p = 0.029) and six
areas for surface area (V1: p = 0.008, V2: p = 0.004, V3: p = 0.007,
V4: p = 0.0333, LO1: p = 0.015, TO1: p = 0.046).
DISCUSSION
The aim of this study was to investigate any potential
morphological changes in visual regions of the brain in
participants with ACHM compared to normally sighted controls.
Significant reductions were found in ACHM relative to
controls for both volume and surface area, but not for
thickness. Decreased volume appears to be driven largely by
reductions in surface area rather than thickness. Our results
reveal widespread morphological alterations throughout the
visual cortex, consistent with previous neuroimaging studies of
congenitally blind adults (Ptito et al., 2008; Aguirre et al., 2016;
Bridge and Watkins, 2019). It appears that ventral visual area
V4 is disproportionately affected by reductions in surface area
and volume compared to the dorsal pathway areas V3a and V3b.
Higher visual areas LO1 and TO1 also are reduced in surface
area in ACHM, although not enough to drive differences in
volume measurements.
Early Visual Area Results
All early visual areas (V1, V2, and V3) showed significant
decreases in grey matter volume and surface area for ACHM.
These areas all have particularly large foveal representations
(Wandell et al., 2007), suggesting that the substantial reduction
in input to these regions in ACHM may explain the decrease
in size. All of these areas also process colour information
(Mullen et al., 2007; Railo et al., 2012; Hurme et al., 2020),
which could contribute further reductions in these areas. In a
separate study, we have extended our analysis to investigate more
specifically the eccentricity dependence of structural changes
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TABLE 3 | Post hoc between group comparisons following analysis of variance in
Table 2, Bonferroni-corrected.













Significance is illustrated by boldface.
within primary visual cortex and shows that cortical changes
are most pronounced in central visual field representations
(manuscript submitted and under review; preprint available
under Molz et al., 2021).
V4 and V3a/b Differences
Ventral area V4 was significantly lower in both surface area and
volume in ACHM compared to controls. No such difference is
found in dorsal areas V3a and V3b, however. This may be driven
by the reduction in foveal input in ACHM, which is largely
dominated by cone photoreceptors in normally-sighted adults.
Previous research has demonstrated a preferential response bias
to stimuli from the central visual field in ventral visual areas
including V4, VO-1, and VO-2 (Brewer et al., 2005; Arcaro et al.,
2009; Winawer and Witthoft, 2015). In contrast, dorsal areas
appear to have an increasingly peripheral bias as one moves up
the visual processing hierarchy away from primary visual cortex
(Tootell et al., 1997; Wandell et al., 2007; Fattori et al., 2009).
Areas with amore peripheral bias should therefore be less affected
by ACHM, since peripheral vision is relatively preserved in these
participants and rod function is intact. Our results showing no
significant differences in ACHM in dorsal areas V3a and V3b
support this hypothesis.
Ventral areas such as V4 have also been associated with
chromatic vision (Bartels and Zeki, 2000; Wade et al., 2002;
Brewer et al., 2005; Mullen et al., 2007, 2015; Bannert and Bartels,
2018), while dorsal regions V3a and V3b have been more aligned
with motion processing (Tootell et al., 1997; Wandell et al., 2007;
Fattori et al., 2009). Therefore, both the lack of chromatic signals
and the reduction of foveal inputs caused by the absence of
functional cones are likely to contribute to differences observed
in V4 (but not V3a or V3b) in ACHM.
Higher Visual Areas
LO1 was also significantly reduced in surface area in ACHM
participants. This area is commonly associated with processing
of shape and object recognition (Malach et al., 1995; Larsson and
Heeger, 2006; Silson et al., 2013) a skill assisted by chromatic
vision (Bramão et al., 2011, 2016). LO1 also exhibits a foveal bias
(Larsson and Heeger, 2006). Therefore, the cortical deprivation
thought to cause this morphological difference may be related to
both the lack of foveal and chromatic input to this area.
TO1 also shows a lower surface area in ACHM. This area is
part of human area MT+, is most commonly associated with
visual motion processing, and has a large foveal representation
(Amano et al., 2009). Individuals with ACHM often report
problems with motion perception, which is generally impaired
when mediated by rods compared to cones (Gegenfurtner et al.,
1999), possibly due to lower temporal resolution of the rods (Hess
and Nordby, 1986). Thus, both reduced foveal inputs as well as
impaired motion processing may explain differences in TO1 in
ACHM. This is in contrast to TO2, which has a greater emphasis
of the peripheral visual field (Amano et al., 2009) and did not
differ significantly between groups.
Surprisingly, ventral areas VO1 and VO2 do not show
significant differences in any metric, an unexpected result as
both have been associated with chromatic vision (Brewer et al.,
2005; Jiang et al., 2007; Arcaro et al., 2009) and have large
foveal representations (Brewer et al., 2005). It is unexpected that
we failed to detect group differences in VO1 and VO2, which
likely receive predominant cone input because of their role in
colour processing. Unlike larger areas V1, V2, V3, V3a/b, and V4,
smaller regions such as VO1 and VO2 are more likely to be prone
to type two errors, which might explain the lack of sensitivity in
revealing differences here, although we did detect differences in
similarly sized areas such as LO1 and TO1. However, research
has suggested that it is more difficult to map areas along the
ventral surface accurately due to potential vessel artifacts (the
‘venous eclipse’), which might have introduced some uncertainty
to area boundaries (Winawer et al., 2010; Benson and Winawer,
2018). Such factors could have contributed to the null result we
found in small ventral areas such as VO1 and VO2 using an
atlas-based approach.
Cortical Thickness
We found no significant differences in cortical thickness in
ACHM in any visual area. This is in contrast to increased cortical
thickness reported in primary visual cortex in participants with
total congenital blindness (Jiang et al., 2009; Park et al., 2009;
Aguirre et al., 2016; Bridge and Watkins, 2019). However, it
is important to note that participants with ACHM are still
sighted, with an area of absolute blindness restricted only to the
central fovea. Our prediction therefore would be that cortical
thickening would be observed only in representations of the
central visual field. Indeed, our preliminary analysis has found
increased cortical thickness in the most central representations of
primary visual cortex in ACHM (Molz et al., 2021). It remains to
be seen if a total absence of input from the central fovea results in
thickening of the foveal representation within higher visual areas.
CONCLUSION
In summary, this study provides an overview of the structural
changes present in visual cortex in ACHM compared to
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normally-sighted controls. This study has revealed widespread
reduction in the surface area and volume of many visual
areas. Differences are found particularly in areas that typically
have large representations of the fovea and areas associated
with chromatic vision, suggesting that both characteristics
of cone vision that are absent in ACHM can affect brain
morphology. It is important to remember drawing conclusions
from this data that atlas-defined ROIs are based on neurotypical
individuals. Therefore, when applying an atlas to brains
that may differ structurally there may be limitations on
the precision of defining the ROIs. However, this technique
has been used successfully in the past and there does
appear to be some specificity in the ROIs where group
differences are found (Norman and Thaler, 2019). Also,
there is evidence that topographical organisation of visual
cortex follows retinotopic principles, even in congenitally blind
individuals (Striem-Amit et al., 2015). An atlas-based approach
can therefore be effective in identifying differences between
groups, particularly when comparing with a neurotypical
control group.
Structural differences in visual cortex in ACHM are important
to consider when planning treatment, such as gene therapy
to restore cone function to the eye. By adulthood, it is
clear that deprivation of chromatic and foveal information
has resulted in cortical remodelling, and it is difficult to
establish from the literature whether this will limit the success
of treatment or if sufficient plasticity remains into adulthood
to permit the restoration of function. Research has shown
that the volume and surface area of primary visual cortex
mature earlier than other brain areas (Leuba and Kraftsik,
1994), completed by the end of the first postnatal year. Less
is known about the rate of development of higher cortical
areas, or whether structural changes in these areas will affect
their ability to perform specialised visual functions. Given
the rapid maturation of primary visual cortex, however, it
seems advisable to apply any therapeutic interventions as
early as possible.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will
be made available by the authors, following appropriate data
protection guidelines.
ETHICS STATEMENT
The study was in accordance with the Declaration of Helsinki,
and was reviewed and approved by each of the site-specific
ethics committees: the York Neuroimaging Centre Research
Ethics Committee (York), the Hadassah Hebrew University
Medical Centre Ethics Committee (Jerusalem), and the Ethical
Committee of the Otto von Guericke University Magdeburg,
Germany (Magdeburg). The participants provided their written
informed consent to participate in this study.
AUTHOR CONTRIBUTIONS
HB, NL, MH, AM, and BM conceived and designed the
experiments. BM, PB, AH, RL, NL, NR, AG, KA, RM, IG, SK, LC,
JM, MK, BK-K, IW, and EB data acquisition. BM, AH, and PB
performed the experiments. RL, LW, and BM analysed the data.
RL and LW wrote the paper. HB, RL, LW, BM, AM, MH, PB,
AH, NL, NR, AG, KA, RM, IG, SK, LC, JM, MK, BK-K, IW, and
EB revised the manuscript. All authors contributed to the article
and approved the submitted version.
FUNDING
This project was supported by European Union’s Horizon
2020 Research and Innovation Programme under the Marie
Sklodowska-Curie grant agreement (No. 641805) and the
German Research Foundation (DFG, HO 2002/12-1).
ACKNOWLEDGMENTS
We thank the German patient association ‘Achromatopsie
Selbsthilfe e.V.’ for support in participant recruitment. We also
thank Elisa Zamboni for her helpful advice on the use of the
Benson atlas and figure preparation.
SUPPLEMENTARY MATERIAL




Aboshiha, J., Dubis, A. M., Carroll, J., Hardcastle, A. J., andMichaelides, M. (2016).
The cone dysfunction syndromes. Br. J. Ophthalmol. 100, 115–121.
Ackroyd, C., Humphrey, N. K., and Warrington, E. K. (1974). Lasting effects of
early blindness: a case study. Q. J. Exp. Psychol. 26, 114–124.
Aguirre, G. K., Datta, R., Benson, N. C., Prasad, S., Jacobson, S. G., Cideciyan, A. V.,
et al. (2016). Patterns of individual variation in visual pathway structure and
function in the sighted and blind. PLoS One 11:e0164677.
Amano, K., Wandell, B. A., and Dumoulin, S. O. (2009). Visual field maps,
population receptive field sizes, and visual field coverage in the human MT+
complex. J. Neurophysiol. 102, 2704–2718. doi: 10.1152/jn.00102.2009
Arcaro, M. J., McMains, S. A., Singer, B. D., and Kastner, S. (2009). Retinotopic
organization of human ventral visual cortex. J. Neurosci. 29, 10638–10652.
Bannert, M. M., and Bartels, A. (2018). Human V4 activity patterns predict
behavioral performance in imagery of object color. J. Neurosci. 38, 3657–3668.
doi: 10.1523/JNEUROSCI.2307-17.2018
Bartels, A., and Zeki, S. (2000). The architecture of the colour centre in the
human visual brain: new results and a review. Eur. J. Neurosci. 12, 172–193.
doi: 10.1046/j.1460-9568.2000.00905.x
Benson, N. C., Butt, O. H., Brainard, D. H., and Aguirre, G. K. (2014).
Correction of distortion in flattened representations of the cortical surface
allows prediction of V1-V3 functional organization from anatomy. PLoS
Comput. Biol. 10:e1003538. doi: 10.1371/journal.pcbi.1003538
Frontiers in Neuroscience | www.frontiersin.org 8 October 2021 | Volume 15 | Article 718958
Lowndes et al. Structural Brain Differences in Achromatopsia
Benson, N. C., and Winawer, J. (2018). Bayesian analysis of retinotopic maps. Elife
6:e40224. doi: 10.7554/eLife.40224
Boucard, C. C., Hernowo, A. T., Maguire, R. P., Jansonius, N. M., Roerdink,
J. B., Hooymans, J. M., et al. (2009). Changes in cortical grey matter density
associated with long-standing retinal visual field defects. Brain 132, 1898–1906.
doi: 10.1093/brain/awp119
Bramão, I., Reis, A., Petersson, K. M., and Faísca, L. (2011). The role of color
information on object recognition: a review and meta-analysis. Acta Psychol.
(Amst.) 138, 244–253. doi: 10.1016/j.actpsy.2011.06.010
Bramão, I., Reis, A., Petersson, K. M., and Faísca, L. (2016). Knowing that
strawberries are red and seeing red strawberries: the interaction between surface
colour and colour knowledge information. J. Cogn. Psychol. 28, 641–657. doi:
10.1080/20445911.2016.1182171
Brewer, A. A., Liu, J., Wade, A. R., and Wandell, B. A. (2005). Visual field maps
and stimulus selectivity in human ventral occipital cortex. Nat. Neurosci. 8,
1102–1109. doi: 10.1038/nn1507
Bridge, H., and Watkins, K. E. (2019). Structural and functional brain
reorganisation due to blindness: the special case of bilateral congenital
anophthalmia. Neurosci. Biobehav. Rev. 107, 765–774. doi: 10.1016/j.neubiorev.
2019.10.006
Brown, H. D., Woodall, R. L., Kitching, R. E., Baseler, H. A., and Morland, A. B.
(2016). Using magnetic resonance imaging to assess visual deficits: a review.
Ophthalmic Physiol. Opt. 36, 240–265. doi: 10.1111/opo.12293
Burton, E.,Wattam-Bell, J. S., Rubin, G., Aboshiha, J., Michaelides,M., Atkinson, J.,
et al. (2016). Dissociations in coherence sensitivity reveal atypical development
of cortical visual processing in congenital achromatopsia. Invest. Ophthalmol.
Vis. Sci. 57, 2251–2259. doi: 10.1167/iovs.15-18414
Castaldi, E., Cicchini, G. M., Cinelli, L., Biagi, L., Rizzo, S., and Morrone, M. C.
(2016). Visual BOLD response in late blind subjects with Argus II retinal
prosthesis. PLoS Biol. 14:e1002569.
Chiu, W., Lin, T.-Y., Chang, Y.-C., Isahwan-Ahmad Mulyadi Lai, H., Lin, S.-C.,
Ma, C., et al. (2021). An update on gene therapy for inherited retinal dystrophy:
experience in leber congenital amaurosis clinical trials. Int. J. Mol. Sci.
22:4534.
Dale, A. M., Fischl, B., and Sereno, M. I. (1999). Cortical surface-based analysis. I.
Segmentation and surface reconstruction.Neuroimage 9, 179–194. doi: 10.1006/
nimg.1998.0395
Desikan, R. S., Ségonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker,
D., et al. (2006). An automated labeling system for subdividing the human
cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage
31, 968–980. doi: 10.1016/j.neuroimage.2006.01.021
Farahbakhsh, M., Anderson, E. J., Rider, A., Greenwood, J. A., Hirji, N., Zaman, S.,
et al. (2020). A demonstration of cone function plasticity after gene therapy in
achromatopsia.medRxiv [Preprint]. doi: 10.1101/2020.12.16.20246710
Fattori, P., Pitzalis, S., and Galletti, C. (2009). The cortical visual area V6 in
macaque and human brains. J. Physiol. Paris 103, 88–97. doi: 10.1016/j.
jphysparis.2009.05.012
Fine, I., Wade, A., Brewer, A., May, M. G., Goodman, D. F., Boynton, G. M.,
et al. (2003). Long-term deprivation affects visual perception and cortex. Nat.
Neurosci. 6, 915–916. doi: 10.1038/nn1102
Fischer, M. D., Michalakis, S., Wilhelm, B., Zobor, D., Muehlfriedel, R., Kohl,
S., et al. (2020). Safety and vision outcomes of subretinal gene therapy
targeting cone photoreceptors in achromatopsia: a nonrandomized controlled
trial. JAMA Ophthalmol. 138, 643–651. doi: 10.1001/jamaophthalmol.2020.
1032
Fischl, B., and Dale, A. M. (2000). Measuring the thickness of the human cerebral
cortex from magnetic resonance images. Proc. Natl. Acad. Sci. U. S. A. 97,
11050–11055. doi: 10.1073/pnas.200033797
Fischl, B., Sereno, M. I., and Dale, A. M. (1999). Cortical surface-based analysis.
II: inflation, flattening, and a surface-based coordinate system. Neuroimage 9,
195–207. doi: 10.1006/nimg.1998.0396
Francois, J. (1961). Heredity in Ophthalmology. St. Louis: Mosby, 497–512.
Gegenfurtner, K., Mayser, H., and Sharpe, L. (1999). Seeing movement in the dark.
Nature 398, 475–476. doi: 10.1038/19004
Goddard, E., Mannion, D. J., McDonald, J. S., Solomon, S. G., and Clifford, C. W.
(2011). Color responsiveness argues against a dorsal component of human V4.
J. Vis. 11:3. doi: 10.1167/11.4.3
Goodale, M. A., and Milner, A. D. (1992). Separate visual pathways for perception
and action. Trends Neurosci. 15, 20–25. doi: 10.1016/0166-2236(92)90
344-8
Guerreiro, M. J., Erfort, M. V., Henssler, J., Putzar, L., and Röder, B. (2015).
Increased visual cortical thickness in sight-recovery individuals. Hum Brain
Mapp. 36, 5265–5274. doi: 10.1002/hbm.23009
Guerreiro, M. J. S., Putzar, L., and Röder, B. (2016). Persisting cross-modal
changes in sight-recovery individuals modulate visual perception. Curr. Biol.
26, 3096–3100. doi: 10.1016/j.cub.2016.08.069
Hadad, B., Schwartz, S., Maurer, D., and Lewis, T. L. (2015). Motion perception: a
review of developmental changes and the role of early visual experience. Front.
Integr. Neurosci. 9:49. doi: 10.3389/fnint.2015.00049
Haegerstrom-Portnoy, G., Schneck, M. E., Verdon, W. A., and Hewlett, S. E.
(1996a). Clinical vision characteristics of the congenital achromatopsias. I.
Visual acuity, refractive error, and binocular status.Optom. Vis. Sci. 73, 446–456.
doi: 10.1097/00006324-199607000-00001
Haegerstrom-Portnoy, G., Schneck, M. E., Verdon, W. A., and Hewlett, S. E.
(1996b). Clinical vision characteristics of the congenital achromatopsias. II.
Color vision. Optom. Vis. Sci. 73, 457–465. doi: 10.1097/00006324-199607000-
00002
Hanson, R. L. W., Gale, R. P., Gouws, A. D., Airody, A., Scott, M. T. W., Akthar,
F., et al. (2019). Following the status of visual cortex over time in patients with
macular degeneration reveals atrophy of visually deprived brain regions. Invest.
Ophthalmol. Vis. Sci. 60, 5045–5051. doi: 10.1167/iovs.18-25823
Hernowo, A. T., Prins, D., Baseler, H. A., Plank, T., Gouws, A. D., Hooymans,
J. M., et al. (2014). Morphometric analyses of the visual pathways in macular
degeneration. Cortex 56, 99–110. doi: 10.1016/j.cortex.2013.01.003
Hess, R. F., and Nordby, K. (1986). Spatial and temporal limits of vision in the
achromat. J. Physiol. 371, 365–385. doi: 10.1113/jphysiol.1986.sp015981
Hirji, N., Aboshiha, J., Georgiou, M., Bainbridge, J., and Michaelides, M. (2018).
Achromatopsia: clinical features, molecular genetics, animal models and
therapeutic options. Ophthalmic Genet. 39, 149–157. doi: 10.1080/13816810.
2017.1418389
Hurme, M., Koivisto, M., Henriksson, L., and Railo, H. (2020). Neuronavigated
TMS of early visual cortex eliminates unconscious processing of chromatic
stimuli. Neuropsychologia 136:107266. doi: 10.1016/j.neuropsychologia.2019.
107266
Jiang, J., Zhu, W., Shi, F., Liu, Y., Li, J., Qin, W., et al. (2009). Thick visual cortex in
the early blind. J. Neurosci. 29, 2205–2211. doi: 10.1523/JNEUROSCI.5451-08.
2009
Jiang, Y., Zhou, K., and He, S. (2007). Human visual cortex responds to invisible
chromatic flicker. Nat. Neurosci. 10, 657–662. doi: 10.1038/nn1879
Johnson, S., Michaelides, M., Aligianis, I. A., Ainsworth, J. R., Mollon, J. D., Maher,
E. R., et al. (2004). Achromatopsia caused by novel mutations in both CNGA3
and CNGB3. J. Med. Genet. 41:e20. doi: 10.1136/jmg.2003.011437
Kohl, S., Jägle, H., Wissinger, B., and Zobor, D. (2004). “Achromatopsia,” in
GeneReviews R© [Internet], eds M. P. Adam, H. H. Ardinger, R. A. Pagon,
S. E. Wallace, L. J. H. Bean, K. Stephens, et al. (Seattle, WA: University of
Washington), 1993–2020.
Larsson, J., and Heeger, D. J. (2006). Two retinotopic visual areas in human lateral
occipital cortex. J. Neurosci. 26, 13128–13142. doi: 10.1523/JNEUROSCI.1657-
06.2006
Leuba, G., and Kraftsik, R. (1994). Changes in volume, surface estimate, three-
dimensional shape and total number of neurons of the human primary visual
cortex from midgestation until old age. Anat. Embryol. (Berl.) 190, 351–366.
doi: 10.1007/BF00187293
Liang, X., Dong, F., Li, H., Li, H., Yang, L., and Sui, R. (2015). Novel CNGA3
mutations in Chinese patients with achromatopsia. Br. J. Ophthalmol. 99,
571–576. doi: 10.1136/bjophthalmol-2014-305432
Lin, H., Zhang, L., Lin, D., Chen, W., Zhu, Y., Chen, C., et al. (2018). Visual
restoration after cataract surgery promotes functional and structural brain
recovery. EBioMedicine 30, 52–61.
Lou, A. R., Madsen, K. H., Julian, H. O., Toft, P. B., Kjaer, T. W., Paulson, O. B.,
et al. (2013). Postoperative increase in grey matter volume in visual cortex after
unilateral cataract surgery. Acta Ophthalmol. 91, 58–65.
Malach, R., Reppas, J. B., Benson, R. R., Kwong, K. K., Jiang, H., Kennedy, W. A.,
et al. (1995). Object-related activity revealed by functional magnetic resonance
Frontiers in Neuroscience | www.frontiersin.org 9 October 2021 | Volume 15 | Article 718958
Lowndes et al. Structural Brain Differences in Achromatopsia
imaging in human occipital cortex. Proc. Natl. Acad. Sci. U. S. A. 92, 8135–8139.
doi: 10.1073/pnas.92.18.8135
McKeefry, D. J., and Zeki, S. (1997). The position and topography of the human
colour centre as revealed by functional magnetic resonance imaging. Brain 120,
2229–2242. doi: 10.1093/brain/120.12.2229
McKyton, A., Averbukh, E., Marks Ohana, D., Levin, N., and Banin, E. (2021).
Cortical visual mapping following ocular gene augmentation therapy for
achromatopsia. J. Neurosci. 41, 7363–7371. doi: 10.1523/JNEUROSCI.3222-20.
2021
Molz, B., Herbik, A., Baseler, H. A., de Best, P. B., Vernon, R., Raz, N., et al. (2021).
Structural changes to primary visual cortex in the congenital absence of cone
input in achromatopsia.medRxiv [Preprint]. doi: 10.1101/2021.07.19.21260427
Mowad, T. G., Willett, A. E., Mahmoudian, M., Lipin, M., Heinecke, A., Maguire,
A. M., et al. (2020). Compensatory cross-modal plasticity persists after sight
restoration. Front. Neurosci. 14:291. doi: 10.3389/fnins.2020.00291
Mullen, K. T., Chang, D. H., and Hess, R. F. (2015). The selectivity of responses to
red-green colour and achromatic contrast in the human visual cortex: an fMRI
adaptation study. Eur. J. Neurosci. 42, 2923–2933. doi: 10.1111/ejn.13090
Mullen, K. T., Dumoulin, S. O., McMahon, K. L., de Zubicaray, G. I., and Hess,
R. F. (2007). Selectivity of human retinotopic visual cortex to S-cone-opponent,
L/M-cone-opponent and achromatic stimulation. Eur. J. Neurosci. 25, 491–502.
doi: 10.1111/j.1460-9568.2007.05302.x
Norman, L. J., and Thaler, L. (2019). Retinotopic-like maps of spatial sound
in primary ‘visual’cortex of blind human echolocators. Proc. Royal Soc. B
286:20191910.
Park, H. J., Lee, J. D., Kim, E. Y., Park, B., Oh, M. K., Lee, S., et al. (2009).
Morphological alterations in the congenital blind based on the analysis of
cortical thickness and surface area. Neuroimage 47, 98–106. doi: 10.1016/j.
neuroimage.2009.03.076
Prins, D., Hanekamp, S., and Cornelissen, F. W. (2016). Structural brain MRI
studies in eye diseases: are they clinically relevant? A review of current findings.
Acta Ophthalmol. 94, 113–121. doi: 10.1111/aos.12825
Ptito, M., Schneider, F. C., Paulson, O. B., and Kupers, R. (2008). Alterations
of the visual pathways in congenital blindness. Exp. Brain Res. 187, 41–49.
doi: 10.1007/s00221-008-1273-4
Railo, H., Salminen-Vaparanta, N., Henriksson, L., Revonsuo, A., and Koivisto, M.
(2012). Unconscious and conscious processing of color rely on activity in early
visual cortex: a TMS study. J. Cogn. Neurosci. 24, 819–829. doi: 10.1162/jocn_
a_00172
Reichel, F. F., Michalakis, S., Wilhelm, B., Zobor, D., Muehlfriedel, R., Kohl,
S., et al. (2021). Three-year results of phase I retinal gene therapy trial for
CNGA3-mutated achromatopsia: results of a non randomised controlled trial.
Br. J. Ophthalmol. doi: 10.1136/bjophthalmol-2021-319067 [Epub ahead of
print].
Reislev, N. L., Dyrby, T. B., Siebner, H. R., Kupers, R., and Ptito, M. (2016a).
Simultaneous assessment of white matter changes in microstructure and
connectedness in the blind brain. Neural Plast. 2016:6029241. doi: 10.1155/
2016/6029241
Reislev, N. L., Kupers, R., Siebner, H. R., Ptito, M., and Dyrby, T. B. (2016b).
Blindness alters the microstructure of the ventral but not the dorsal
visual stream. Brain Struct. Funct. 221, 2891–2903. doi: 10.1007/s00429-015-
1078-8
Remmer, M. H., Rastogi, N., Ranka, M. P., and Ceisler, E. J. (2015).
Achromatopsia: a review. Curr. Opin. Ophthalmol. 26, 333–340. doi: 10.1097/
ICU.0000000000000189
Ségonne, F., Dale, A. M., Busa, E., Glessner, M., Salat, D., Hahn, H. K., et al. (2004).
A hybrid approach to the skull stripping problem in MRI. Neuroimage 22,
1060–1075. doi: 10.1016/j.neuroimage.2004.03.032
Ségonne, F., Pacheco, J., and Fischl, B. (2007). Geometrically accurate topology-
correction of cortical surfaces using nonseparating loops. IEEE Trans. Med.
Imaging 26, 518–529. doi: 10.1109/TMI.2006.887364
Silson, E. H., McKeefry, D. J., Rodgers, J., Gouws, A. D., Hymers, M., andMorland,
A. B. (2013). Specialized and independent processing of orientation and shape
in visual field maps LO1 and LO2. Nat. Neurosci. 16, 267–269. doi: 10.1038/nn.
3327
Sled, J. G., Zijdenbos, A. P., and Evans, A. C. (1998). A nonparametric method for
automatic correction of intensity nonuniformity inMRI data. IEEE Trans. Med.
Imaging 17, 87–97. doi: 10.1109/42.668698
Striem-Amit, E., Ovadia-Caro, S., Caramazza, A., Margulies, D. S., Villringer, A.,
and Amedi, A. (2015). Functional connectivity of visual cortex in the blind
follows retinotopic organization principles. Brain 138, 1679–1695.
Sun, W., Li, S., Xiao, X., Wang, P., and Zhang, Q. (2020). Genotypes and
phenotypes of genes associated with achromatopsia: a reference for clinical
genetic testing.Mol. Vis. 26, 588–602.
Thiadens, A. A., Slingerland, N. W., Roosing, S., van Schooneveld, M. J.,
van Lith-Verhoeven, J. J., van Moll-Ramirez, N., et al. (2009). Genetic
etiology and clinical consequences of complete and incomplete achromatopsia.
Ophthalmology 116, 1984–1989.
Tootell, R. B., Mendola, J. D., Hadjikhani, N. K., Ledden, P. J., Liu, A. K., Reppas,
J. B., et al. (1997). Functional analysis of V3A and related areas in human
visual cortex. J. Neurosci. 17, 7060–7078. doi: 10.1523/JNEUROSCI.17-18-
07060.1997
Ungerleider, L. G., and Mishkin, M. (1982). “Two cortical visual systems,” in The
Analysis of Visual Behaviour, eds D. J. Ingle, R. J. W. Mansfield, and M. S.
Goodale (Cambridge, MA: MIT Press), 549–586.
Varsányi, B.,Wissinger, B., Kohl, S., Koeppen, K., and Farkas, Á (2005). Clinical and
genetic features of Hungarian achromatopsia patients.Mol. Vis. 11, 996–1001.
Wade, A. R., Brewer, A. A., Rieger, J. W., and Wandell, B. A. (2002). Functional
measurements of human ventral occipital cortex: retinotopy and colour. Philos.
Trans. R. Soc. Lond. B Biol. Sci. 357, 963–973. doi: 10.1098/rstb.2002.1108
Wandell, B. A., Dumoulin, S. O., and Brewer, A. A. (2007). Visual field maps in
human cortex. Neuron 56, 366–383. doi: 10.1016/j.neuron.2007.10.012
Winawer, J., Horiguchi, H., Sayres, R. A., Amano, K., and Wandell, B. A. (2010).
Mapping hV4 and ventral occipital cortex: the venous eclipse. J. Vis. 10:1.
Winawer, J., and Witthoft, N. (2015). Human V4 and ventral occipital retinotopic
maps. Vis. Neurosci. 32:E020. doi: 10.1017/S0952523815000176
Winkler, A. M., Greve, D. N., Bjuland, K. J., Nichols, T. E., Sabuncu, M. R., Håberg,
A. K., et al. (2018). Joint analysis of cortical area and thickness as a replacement
for the analysis of the volume of the cerebral cortex. Cereb. Cortex 28, 738–749.
doi: 10.1093/cercor/bhx308
Wissinger, B., Gamer, D., Jägle, H., Giorda, R., Marx, T., Mayer, S., et al. (2001).
CNGA3 mutations in hereditary cone photoreceptor disorders. Am. J. Hum.
Genet. 69, 722–737.
Wong, A. M. (2012). New concepts concerning the neural mechanisms of
amblyopia and their clinical implications. Can. J. Ophthalmol. 47, 399–409.
Yucel, Y. H., and Gupta, N. (2015). A framework to explore the visual brain in
glaucoma with lessons from models and man. Exp. Eye Res. 141, 171–178.
doi: 10.1016/j.exer.2015.07.004 Epub 2015 Jul 11.
Zeki, S. (1990). A century of cerebral achromatopsia. Brain 113, 1721–1777. doi:
10.1093/brain/113.6.1721
Zeki, S.,Watson, J. D., Lueck, C. J., Friston, K. J., Kennard, C., and Frackowiak, R. S.
(1991). A direct demonstration of functional specialization in human visual
cortex. J. Neurosci. 11, 641–649. doi: 10.1523/JNEUROSCI.11-03-00641.1991
Zelinger, L., Cideciyan, A. V., Kohl, S., Schwartz, S. B., Rosenmann, A., Eli, D., et al.
(2015). Genetics and disease expression in the CNGA3 form of achromatopsia:
steps on the path to gene therapy. Ophthalmology 122, 997–1007. doi: 10.1016/
j.ophtha.2014.11.025
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Publisher’s Note: All claims expressed in this article are solely those of the authors
and do not necessarily represent those of their affiliated organizations, or those of
the publisher, the editors and the reviewers. Any product that may be evaluated in
this article, or claim that may be made by its manufacturer, is not guaranteed or
endorsed by the publisher.
Copyright © 2021 Lowndes, Molz, Warriner, Herbik, de Best, Raz, Gouws, Ahmadi,
McLean, Gottlob, Kohl, Choritz, Maguire, Kanowski, Käsmann-Kellner, Wieland,
Banin, Levin, Hoffmann, Morland and Baseler. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Neuroscience | www.frontiersin.org 10 October 2021 | Volume 15 | Article 718958
